Monopar Therapeutics Inc. (MNPR) stock price, financials & research | GoAI

Regular session · ET · Market data may be delayed.

GoAI snapshot

Jul 10, 2026

48/ 100

GoAI Score

Hold

Valuation

40

Expensive

Sentiment

63

Bullish

Risk

47

Elevated Risk

Momentum

64

Gaining

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

Company profile

Industry: Biotechnology
Sector: Healthcare
Headquarters: US

Market position

Day range

Current $83.98

$81.265$85.49

52-week range

Current $83.98

$50.07$124.82

Open: $82.48
Previous close: $83.78
Volume: 185.51K
Market cap: 562.59M USD
50-day average: $105.34; -20.28% below average
200-day average: $76.6457; +9.57% above average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value: 422.26M USD
P/E (TTM): -35.89×
P/B (TTM): 5.48×
P/S (TTM): 0×
EV / EBITDA: -30.78×
Earnings yield: -2.83%
Free cash flow yield: -2.52%
Dividend yield: 0.00%

Profitability & efficiency

Gross margin: 0.00%
Operating margin: 0.00%
Net margin: 0.00%
Return on equity: -9.95%
Return on assets: -9.75%
Return on invested capital: -12.11%

Financial health

Debt / equity: 0×
Current ratio: 51.35×
Altman Z-score: 81.34
Piotroski F-score: 0 of 9

Financial statements

Income trends

Operating income

−16.7M USD-3.36%

Net income

−13.72M USD+11.99%

Financial statements: Income statement
Metric (USD)	FY2025	FY2024	FY2023	FY2022	FY2021
Research and development	9.9B USD	13.01M USD	5.6M USD	7.59M USD	6.49M USD
Selling, general, and administrative	6.8B USD	3.16M USD	3.23M USD	2.95M USD	2.63M USD
Operating expenses	16.7M USD	16.16M USD	8.83M USD	10.54M USD	9.13M USD
Interest income	2.99M USD	404.02K USD	429.04K USD	21.24K USD	24.02K USD
Operating income	−16.7M USD	−16.16M USD	−8.83M USD	−10.54M USD	−9.13M USD
Net income	−13.72M USD	−15.59M USD	−8.4M USD	−10.52M USD	−9.1M USD

Company facts updated Oct 9, 2026.

Earnings

Latest fiscal-year EPS: -1.85; FY2025
Latest fiscal-year revenue: 0 USD; FY2025

Annual EPS trend

Reported history and fiscal-year consensus

ReportedConsensus forecast

Annual revenue trend

Reported history and fiscal-year consensus

ReportedConsensus forecast

Analyst ratings

Third-party consensus; not a GoAI recommendation.

Analyst price target

Average target

$126

50.04% upside

Past 12 months12-month forecastHigh $145Average $126Low $105

Rating distribution

14 ratings

Strong buy00%

Buy1179%

Hold321%

Sell00%

Strong sell00%

MNPR peers

Amgen Inc.

AMGN

Amgen Inc.

$407.44

-1.37%

Gilead Sciences, Inc.

GILD

Gilead Sciences, Inc.

$147.1

+0.17%

Intuitive Surgical, Inc.

ISRG

Intuitive Surgical, Inc.

$415.41

+0.21%

Vertex Pharmaceuticals Incorporated

VRTX

Vertex Pharmaceuticals Incorporated

$503.25

-0.47%

Sanofi

SNY

Sanofi

$40.23

+0.07%

Moderna, Inc.

MRNA

Moderna, Inc.

$197

+0.26%

ETFs holding MNPR

Funds reporting this stock among their holdings, ordered by reported position size.

ETFMarket valueWeightAUMExpense ratioPrice / 1D

Vanguard Morningstar Total Stock Market ETF

Vanguard Morningstar Total Stock Market ETFVTI17.88M0.00%2.3T USD0.03%$379.56-0.39%

State Street SPDR S&P Biotech ETF

State Street SPDR S&P Biotech ETFXBI11.82M0.12%10.11B USD0.35%$149.29-0.63%

iShares Russell 2000 ETF

iShares Russell 2000 ETFIWM10.16M0.01%77.7B USD0.19%$277.57-0.05%

Vanguard Extended Market ETF

Vanguard Extended Market ETFVXF5.11M0.01%95.4B USD0.05%$233.13-0.15%

Vanguard Russell 2000 ETF

Vanguard Russell 2000 ETFVTWO2.9M0.02%18B USD0.06%$112.1-0.10%

Vanguard U.S. Momentum Factor ETF

Vanguard U.S. Momentum Factor ETFVFMO1.7M0.08%1.9B USD0.13%$227.78-0.44%

iShares Micro-Cap ETF

iShares Micro-Cap ETFIWC1.18M0.09%1.32B USD0.60%$182.79-0.31%

iShares Russell 2000 Growth ETF

iShares Russell 2000 Growth ETFIWO884.38K0.01%14.04B USD0.24%$353.47-0.53%

Vanguard Morningstar Total Stock Market ETF

Vanguard Morningstar Total Stock Market ETFVTI

Market value: 17.88M
Weight: 0.00%
AUM: 2.3T USD
Expense ratio: 0.03%
Price / 1D: $379.56-0.39%

State Street SPDR S&P Biotech ETF

State Street SPDR S&P Biotech ETFXBI

Market value: 11.82M
Weight: 0.12%
AUM: 10.11B USD
Expense ratio: 0.35%
Price / 1D: $149.29-0.63%

iShares Russell 2000 ETF

iShares Russell 2000 ETFIWM

Market value: 10.16M
Weight: 0.01%
AUM: 77.7B USD
Expense ratio: 0.19%
Price / 1D: $277.57-0.05%

Vanguard Extended Market ETF

Vanguard Extended Market ETFVXF

Market value: 5.11M
Weight: 0.01%
AUM: 95.4B USD
Expense ratio: 0.05%
Price / 1D: $233.13-0.15%

Vanguard Russell 2000 ETF

Vanguard Russell 2000 ETFVTWO

Market value: 2.9M
Weight: 0.02%
AUM: 18B USD
Expense ratio: 0.06%
Price / 1D: $112.1-0.10%

Vanguard U.S. Momentum Factor ETF

Vanguard U.S. Momentum Factor ETFVFMO

Market value: 1.7M
Weight: 0.08%
AUM: 1.9B USD
Expense ratio: 0.13%
Price / 1D: $227.78-0.44%

iShares Micro-Cap ETF

iShares Micro-Cap ETFIWC

Market value: 1.18M
Weight: 0.09%
AUM: 1.32B USD
Expense ratio: 0.60%
Price / 1D: $182.79-0.31%

iShares Russell 2000 Growth ETF

iShares Russell 2000 Growth ETFIWO

Market value: 884.38K
Weight: 0.01%
AUM: 14.04B USD
Expense ratio: 0.24%
Price / 1D: $353.47-0.53%

Continue in GoAI

AI-generated and delayed market data for informational and educational purposes only. Not investment advice.